United States· US:61734-030_5488afee-9d3b-ff80-e063-6394a90a29f9
Vaporizing Colds Rub
A medicinal product containing menthol; eucalyptus oil; camphor (synthetic), registered in United States by Delon Laboratories (1990) Ltd.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MENTHOL; EUCALYPTUS OIL; CAMPHOR (SYNTHETIC)
- Manufacturer
- Delon Laboratories (1990) Ltd
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1161734-030-02
- ndc1161734-030-03
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eec002e7-7b63-4a49-aeee-bf737ebf3939 GET /v1/drugs/eec002e7-7b63-4a49-aeee-bf737ebf3939?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "2.6; 1.2; 4.73",
"substance": "MENTHOL; EUCALYPTUS OIL; CAMPHOR (SYNTHETIC)",
"productndc": "61734-030",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about menthol; eucalyptus oil; camphor (synthetic).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.